9 Meters Biopharma, Inc. (NMTR) Misses Q1 EPS by 98c

9 Meters Biopharma, Inc. (NASDAQ: NMTR) reported Q1 EPS of ($1.02), $0.98 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on 9 Meters Biopharma, Inc. (NMTR) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c